News & Updates
Filter by Specialty:
Oral minoxidil may be a viable alternative to topical treatment for male pattern baldness
Low-dose oral minoxidil demonstrates comparable efficacy to 5% topical minoxidil in the treatment of androgenetic alopecia in men, offering a viable option for those who prefer oral therapy or those who poorly tolerate topical treatment, as shown in a study.
Oral minoxidil may be a viable alternative to topical treatment for male pattern baldness
13 Apr 2024
Apixaban cheaper, on par with enoxaparin as VTE prophylaxis in gynaecologic cancer patients
Patients with gynaecologic cancer who used apixaban for postoperative venous thromboembolism (VTE) prophylaxis achieve similar 90-day and lower 30-day rates of VTE when compared with those who used enoxaparin, reports a study presented at SGO 2024.
Apixaban cheaper, on par with enoxaparin as VTE prophylaxis in gynaecologic cancer patients
12 Apr 2024
Maintenance fuzuloparib prolongs survival in ovarian cancer
Maintenance therapy with fuzuloparib results in significant improvements in progression-free survival (PFS) in patients newly diagnosed with advanced ovarian cancer, who showed response to first-line platinum-based chemotherapy (PBC), reports a study (FZOCUS-1) presented at SGO 2024.
